Europe Infectious Disease Molecular Diagnostics Market, 2019-2023: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget.

This new five-country study from the contains 700 pages, 54 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Report Highlights

- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France
- Germany
- Italy
- Spain
- UK

European Market Overview
- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components.

- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.

- A comprehensive analysis of the sequencing market by country and laboratory segment.

- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.

Product/Technology Review

- Comparison of leading infectious disease molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
Decode Genetics
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
LabCorp
Leica Biosystems
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher

- Comprehensive listings of companies developing and marketing infectious disease molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.


I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing
Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Review
A. DNA Sequencing
1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation

6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
4. Test Formats
5. Labeling Techniques
6. Amplification Methods
C. Detection Technologies

1. Radioactive Methods
a. Overview
b. Major Isotopes
O P-32
O S-35
O H-3
O I-125
2. Non-Isotopic Methods
a. Enzymatic Labels
b. Chemical Labeling
O Indirect Chemical Labeling
O Direct Chemical Labeling
c. Fluorescence
d. Chemiluminescence
e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review

1. Abbott LCx
2. Beckman Coulter/Biomek FK
3. BD Viper System with XTR Technology
4. BD Innova
5. Becton Dickinson SDA

6. bioMerieux NucliSENS easyMAG
7. bioMerieux NucliSENS easyQ and MiniMAG
8. Bio-Rad GeneScope
9. Cepheid GeneXpert
10. Curetis Unyvero
11. GenMark Dx eSensor XT-8
12. Hologic/Gen-Probe Panther
13. Hologic/Gen-Probe Tigris/DTS
14. HTG Molecular Edge
15. Life Technologies QuantStudio Dx
16. Qiagen QIAsymphony RGQ
17. Roche Cobas Amplicor
18. Roche Cobas TaqMan 48
19. Roche Cobas TaqMan
20. Roche Cobas TaqMan AmpliPrep
21. Roche LighCycler 480
22. Roche Cobas 4800
23. Roche Cobas s 201
24. Siemens Versant
25. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection
F. Pharmacogenomics
G. Major Applications, Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT,
Western Blot, HTLV-I/II
Adenovirus
Aeromonas
Anthrax/Bacillus Anthracis

Arboviruses
Babesiosis
Bacillary Epithelioid Angiomatosis (BEA)
and Other Bartonella (Rochalimaea)
Blastocystis Hominis
Brucella
Campylobacter
Candida
Chagas Disease
Chancroid
Chlamydia
Clostridium Difficile
Coronaviruses
Coxsackieviruses
Creutzfeldt-Jakobs Disease
Cryptosporidium Parvum
Cyclospora Cayetanensis
Cytomegalovirus
Ebola Virus
E. Coli
EchoVirus
Encephalitis
Enteroviruses
Epstein-Barr Virus
Giardia Lamblia
Gonorrhea
Granuloma Inguinale
Hantavirus
Helicobacter Pylori
Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT
Herpes Simplex Virus
Human Herpes Virus-6 (HHV-6)
Influenza Viruses
Legionella
Lyme Disease
Lymphogranuloma Venereum (LGV)
Malaria
Measles (Rubeola)
Meningitis

Microsporidium
Mononucleosis
Mumps
Mycoplasma
Papillomaviruses
Parvovirus B19
Pneumonia
Polyomaviruses
Pseudomonas Aeruginosa
Rabies
Respiratory Syncytial Virus (RSV)
Rhinoviruses
Rotavirus
Rubella
Salmonellosis
Septicemia
Shigellosis
Staphylococcus Aureus
Streptococci
Syphilis
Toxoplasmosis
Trichomonas Vaginalis
Tuberculosis
Vibrio
West Nile Virus
Yersina
H. Competing/complementing
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry

VII. France Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts,
Major Supplier Sales and Market Shares
VIII. Germany Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts,
Major Supplier Sales and Market Shares
IX. Italy Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts,
Major Supplier Sales and Market Shares
X. Spain Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts,
Major Supplier Sales and Market Shares
XI. U.K. Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts,
Major Supplier Sales and Market Shares

XII. Competitive Assessments

- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- CellMark Forensics/LabCorp
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech/Leica
- Li-Cor Biosciences
- Monogram Biosciences/LabCorp
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
XIII. Appendix: Major Universities and Research Centers
Developing Molecular Diagnostic Technologies

List Of Tables


Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests

Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests

Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests

Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
France
Molecular Diagnostics Test Volume And Sales
By Major Application 2014-2019
France
Laboratories Performing DNA Sequencing
By Market Segment 2014
France
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014

France
Molecular Diagnostics Test Volume
By Major Application 2014-2019
France
Major Infectious Disease Test Volume by Assay 2014-2019
France
Major Infectious Disease Test Volume by Method 2014
France
Molecular Diagnostics Market
By Major Application 2014-2019
France
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
France
Major Infectious Disease Diagnostics Market by Assay 2014-2019
France
AIDS Testing Market
Estimated Sales by Major Supplier 2014
France
Adenovirus Testing Market
Estimated Sales by Major Supplier 2014
France
Chlamydia Testing Market
Estimated Sales by Major Supplier 2014
France
CMV Testing Market
Estimated Sales by Major Supplier 2014
France
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014

France
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014
France
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014
France
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier 2014
France
Herpes Testing Market
Estimated Sales by Major Supplier 2014
France
Influenza Testing Market
Estimated Sales by Major Supplier 2014
France
Meningitis Testing Market
Estimated Sales by Major Supplier 2014
France
Mycoplasma Testing Market
Estimated Sales by Major Supplier 2014
France
RSV Testing Market
Estimated Sales by Major Supplier 2014
France
Shigella Testing Market
Estimated Sales by Major Supplier 2014
Germany
Molecular Diagnostics Test Volume And Sales
By Major Application 2014-2019
Germany
Laboratories Performing DNA Sequencing
By Market Segment 2014

Germany
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014
Germany
Molecular Diagnostics Test Volume
By Major Application 2014-2019
Germany
Major Infectious Disease Test Volume by Assay 2014-2019
Germany
Major Infectious Disease Test Volume by Method 2014
Germany
Molecular Diagnostics Market
By Major Application 2014-2019
Germany
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
Germany
Major Infectious Disease Diagnostics Market by Assay 2014-2019
Germany
AIDS Testing Market
Estimated Sales by Major Supplier 2014
Germany
CMV Testing Market
Estimated Sales by Major Supplier 2014
Germany
EBV Testing Market
Estimated Sales by Major Supplier 2014
Germany
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014

Germany
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014
Germany
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014
Germany
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier 2014
Germany
Herpes Testing Market
Estimated Sales by Major Supplier 2014
Germany
Influenza Testing Market
Estimated Sales by Major Supplier 2014
Germany
Meningitis Testing Market
Estimated Sales by Major Supplier 2014
Germany
Mycoplasma Testing Market
Estimated Sales by Major Supplier 2014
Germany
Pneumonia Testing Market
Estimated Sales by Major Supplier 2014
Germany
RSV Testing Market
Estimated Sales by Major Supplier 2014
Germany
Rotavirus Testing Market
Estimated Sales by Major Supplier 2014

Italy
Molecular Diagnostics Test Volume And Sales
By Major Application 2014-2019
Italy
Laboratories Performing DNA Sequencing
By Market Segment 2014
Italy
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014
Italy
Molecular Diagnostics Test Volume
By Major Application 2014-2019
Italy
Major Infectious Disease Test Volume by Assay 2014-2019
Italy
Major Infectious Disease Test Volume by Method 2014
Italy
Molecular Diagnostics Market
By Major Application 2014-2019
Italy
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
Italy
Major Infectious Disease Diagnostics Market by Assay 2014-2019
Italy
AIDS Testing Market
Estimated Sales by Major Supplier 2014
Italy
CMV Testing Market
Estimated Sales by Major Supplier 2014

Italy
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014
Italy
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014
Italy
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014
Italy
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier 2014
Italy
Herpes Testing Market
Estimated Sales by Major Supplier 2014
Italy
Influenza Testing Market
Estimated Sales by Major Supplier 2014
Italy
Meningitis Testing Market
Estimated Sales by Major Supplier 2014
Italy
Mycoplasma Testing Market
Estimated Sales by Major Supplier 2014
Italy
RSV Testing Market
Estimated Sales by Major Supplier 2014
Spain
Molecular Diagnostics Test Volume And Sales
By Major Application 2014-2019

Spain
Laboratories Performing DNA Sequencing
By Market Segment 2014
Spain
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014
Spain
Molecular Diagnostics Test Volume
By Major Application 2014-2019
Spain
Major Infectious Disease Test Volume by Assay 2014-2019
Spain
Major Infectious Disease Test Volume by Method 2014
Spain
Molecular Diagnostics Market
By Major Application 2014-2019
Spain
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
Spain
Major Infectious Disease Diagnostics Market by Assay 2014-2019
Spain
AIDS Testing Market
Estimated Sales by Major Supplier 2014
Spain
Chlamydia Testing Market
Estimated Sales by Major Supplier 2014
Spain
CMV Testing Market
Estimated Sales by Major Supplier 2014

Spain
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014
Spain
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014
Spain
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014
Spain
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier 2014
Spain
Herpes Testing Market
Estimated Sales by Major Supplier 2014
Spain
Influenza Testing Market
Estimated Sales by Major Supplier 2014
Spain
Meningitis Testing Market
Estimated Sales by Major Supplier 2014
Spain
Mycoplasma Testing Market
Estimated Sales by Major Supplier 2014
U.K.
Molecular Diagnostics Test Volume And Sales
By Major Application 2014-2019
U.K.
Laboratories Performing DNA Sequencing
By Market Segment 2014

U.K.
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014
U.K.
Molecular Diagnostics Test Volume
By Major Application 2014-2019
U.K.
Major Infectious Disease Test Volume by Assay 2014-2019
U.K.
Major Infectious Disease Test Volume by Method 2014
U.K.
Molecular Diagnostics Market
By Major Application 2014-2019
U.K.
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
U.K.
Major Infectious Disease Diagnostics Market by Assay 2014-2019
U.K.
AIDS Testing Market
Estimated Sales by Major Supplier 2014
U.K.
Gonorrhea Testing Market
Estimated Sales by Major Supplier 2014
U.K.
Hepatitis Testing Market
Estimated Sales by Major Supplier 2014
U.K.
Hepatitis C Testing Market
Estimated Sales by Major Supplier 2014

U.K.
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier 2014
U.K.
Influenza Testing Market
Estimated Sales by Major Supplier 2014
U.K.
Mycoplasma Testing Market
Estimated Sales by Major Supplier 2014
U.K.
Pneumonia Testing Market
Estimated Sales by Major Supplier 2014
U.K.
Shigella Testing Market
Estimated Sales by Major Supplier 2014

2020 Europe Virology and Bacteriology Market for over 100 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation, Opportunities

This new report is a five-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in major

USD 19700 View Report

2020 Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation, Opportunities

This new report is a seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in the U.S.,

USD 28500 View Report

2020 US Molecular Blood Typing, Grouping and Infectious Disease NAT Market, 2019-2023: Supplier Shares, Volume and Sales Forecasts by Test and Market Segment, Competitive Strategies, Emerging Technologies, Latest Instrumentation

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years,

USD 4500 View Report

2020 UK Molecular Blood Typing, Grouping and Infectious Disease NAT Market, 2019-2023: Supplier Shares, Volume and Sales Forecasts by Test and Market Segment, Competitive Strategies, Emerging Technologies, Latest Instrumentation

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years,

USD 4500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available